TUSTIN, CA--(Marketwire - November 16, 2009) -
| Highlighted Links |
RPC website |
This filing provides for an extension for the filing of its Quarterly Report on Form 10-Q until November 23, 2009. The Company's Quarterly Report on Form 10-Q for the nine months ended September 30, 2009, could not be filed within the prescribed period because the Company was unable to compile certain information required in order to permit the Company to file a timely and accurate report on the Company's financial condition. This inability could not have been eliminated by the Company without unreasonable effort or expense. We expect to file the Quarterly Report within the allotted time. For additional information contact Radient Pharmaceutical Corporation's Investor Relations at 206.310.5323.
About Radient Pharma:
Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is an integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, and premium skin care products.
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: The statements contained in this document include certain predictions
and projections that may be considered forward-looking statements under
securities law. These statements involve a number of important risks and
uncertainties that could cause actual results to differ materially
including, but not limited to, the performance of joint venture partners,
as well as other economic, competitive and technological factors involving
the Company's operations, markets, services, products, and prices. With
respect to Radient Pharmaceuticals Corporation, except for the historical
information contained herein, the matters discussed in this document are
forward-looking statements involving risks and uncertainties that could
cause actual results to differ materially from those in such
forward-looking statements.
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati:
